Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Market Analysis and Emerging Opportunities
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare, acquired autoimmune disorder characterized by progressive weakness and impaired sensory function in the limbs due to damage to the peripheral nerves. The CIDP market has been experiencing a notable shift, driven by advancements in diagnostics, therapeutic interventions, and growing awareness of rare diseases. Market Growth...
0 Comments 0 Shares 104 Views
Sponsored